Identification of volatile biomarkers of Trichomonas vaginalis infection in vaginal discharge and urine.


Journal

Applied microbiology and biotechnology
ISSN: 1432-0614
Titre abrégé: Appl Microbiol Biotechnol
Pays: Germany
ID NLM: 8406612

Informations de publication

Date de publication:
May 2023
Historique:
received: 16 01 2023
accepted: 12 03 2023
revised: 07 03 2023
medline: 18 4 2023
pubmed: 1 4 2023
entrez: 31 3 2023
Statut: ppublish

Résumé

Trichomoniasis, a disease caused by Trichomonas vaginalis, is the most common non-viral sexually transmitted infection worldwide. The importance of its diagnosis lies in its ease of transmission and the absence of symptoms in most cases, as occurs in men, which have a significant role as asymptomatic carriers. The most widely used diagnostic methods are the fresh examination of vaginal or urethral secretions and molecular techniques. However, as they have some disadvantages and, sometimes, low sensitivity, new trichomoniasis diagnostic methods are necessary. Volatile organic compounds in clinical samples are effective in the diagnosis of different diseases. This work aimed to study, for the first time, those present in vaginal discharge and urine of patients with Trichomonas vaginalis infection to look for volatile biomarkers. The results showed that volatile compounds such as 2-methyl-1-propanol and cyclohexanone could serve as biomarkers in vaginal discharge samples, as well as 2-octen-1-ol and 3-nonanone in urine. Moreover, 3-hydroxy-2,4,4-trimethylpentyl 2-methylpropanoate found in vaginal discharge, highly correlated to positive patients, is also highly related to urines of patients with trichomoniasis. The biomarkers described in this study might be a promising diagnostic tool. KEY POINTS: • The incidence of Trichomonas vaginalis infection is increasing • Trichomonas vaginalis VOC study in vaginal discharge and urine was performed • The identification of volatile biomarkers could allow a new diagnostic method.

Identifiants

pubmed: 37000228
doi: 10.1007/s00253-023-12484-6
pii: 10.1007/s00253-023-12484-6
pmc: PMC10106345
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3057-3069

Informations de copyright

© 2023. The Author(s).

Références

BD MAX™ Vaginal Panel (2018) Package Insert/Clinical Trial Data Accessed 21 September 2022
Beltrán NC, Horváthová L, Jedelský PL, Sedinová M, Rada P, Marcinčiková M, Hrdý I, Tachezy J (2013) Iron-induced changes in the proteome of Trichomonas vaginalis hydrogenosomes. PLoS One 8(5):e65148. https://doi.org/10.1371/journal.pone.0065148
doi: 10.1371/journal.pone.0065148 pubmed: 23741475 pmcid: 3669245
Dittmer KE, Pradhan P, Tompkins QC, Brittingham A, Wilson WA (2021) Cloning and characterization of glycogen branching and debranching enzymes from the parasitic protist Trichomonas vaginalis. Biochimie 186:59–72. https://doi.org/10.1016/j.biochi.2021.04.007
doi: 10.1016/j.biochi.2021.04.007 pubmed: 33895247
Djago F, Lange J, Poinot P (2021) Induced volatolomics of pathologies. Nat Rev Chem 5:183–196. https://doi.org/10.1038/s41570-020-00248-z
doi: 10.1038/s41570-020-00248-z
N Drabińska C Flynn N Ratcliffe I Belluomo A Myridakis O Gould M Fois A Smart T Devine BL Costello (2021) A literature survey of all volatiles from healthy human breath and bodily fluids the human volatilome J Breath Res 15 3 https://doi.org/10.1088/1752-7163/abf1d0
Galán JC, Lepe JA, Otero L, Serra J, Vázquez F (2018) Diagnóstico microbiológico de las infecciones de transmisión sexual y otras infecciones genitales Procedimientos en Microbiología Clínica Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) Accessed 15 October 2022
Hardick J, Yang S, Lin S, Duncan D, Gaydos C (2003) Use of the Roche LightCycler instrument in a real-time PCR for Trichomonas vaginalis in urine samples from females and males. J Clin Microbiol 41 12 5619–5622. https://doi.org/10.1128/JCM.41.12.5619-5622.2003
Herath S, Balendran T, Herath A, Iddawela D, Wickramasinghe S (2021) PLOS One 16(10):e0258556. https://doi.org/10.1371/journal.pone.0258556
doi: 10.1371/journal.pone.0258556 pubmed: 34644344 pmcid: 8513885
Hirt RP, Sherrard J (2015) Trichomonas vaginalis origins, molecular pathobiology and clinical considerations. Curr Opin Infect Dis 28(1):72–79. https://doi.org/10.1097/qco.0000000000000128
doi: 10.1097/qco.0000000000000128 pubmed: 25485651
DE Kleiner M Johnston (1985) Purification and properties of a secondary alcohol dehydrogenase from the parasitic protozoan Tritrichomonas foetus. J Biol Chem 260 13 8038 8043 https://doi.org/10.1016/S0021-9258(17)39560-1
Kunze-Szikszay N, Euler M, Perl T (2021) Identification of volatile compounds from bacteria by spectrometric methods in medicine diagnostic and other areas: current state and perspectives. Appl Microbiol Biotechnol 105(16–17):6245–6255. https://doi.org/10.1007/s00253-021-11469-7
doi: 10.1007/s00253-021-11469-7 pubmed: 34415392 pmcid: 8377328
Kusdian G, Gould SB (2014) The biology of Trichomonas vaginalis in the light of urogenital tract infection. Mol Biochem Parasitol 198(2):92–99. https://doi.org/10.1016/j.molbiopara.2015.01.004
doi: 10.1016/j.molbiopara.2015.01.004 pubmed: 25677793
Lawing LF, Hedges SR, Schwebke JR (2000) Detection of trichomonosis in vaginal and urine specimens from women by culture and PCR. J Clin Microbiol 38(10):3585–3588. https://doi.org/10.1128/jcm.38.10.3585-3588.2000
doi: 10.1128/jcm.38.10.3585-3588.2000 pubmed: 11015368 pmcid: 87441
Leitsch D (2021) Recent advances in the molecular b-ology of the protist parasite Trichomonas vaginalis Fac Rev 10 26. https://doi.org/10.12703/r/10-26
Mehmood T, Liland KH, Snipen L, Sæbø S (2012) A review of variable selection methods in partial least squares regression. Chemom Intell Lab Syst 118(697):62–69. https://doi.org/10.1016/j.chemolab.2012.07.010
doi: 10.1016/j.chemolab.2012.07.010
Mercer F, Johnson PJ (2018) Trichomonas vaginalis: pathogenesis, symbiont interactions, and host cell immune responses. Trends Parasitol 34(8):683–693. https://doi.org/10.1016/j.pt.2018.05.006
doi: 10.1016/j.pt.2018.05.006 pubmed: 30056833
Nye MB, Schwebke JR, Body BA (2009) Comparison of APTIMA Trichomonas vaginalis transcription mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol 200(2):188.e1–7. https://doi.org/10.1016/j.ajog.2008.10.005
doi: 10.1016/j.ajog.2008.10.005 pubmed: 19185101
Rajamanickam R, Baskaran D (2017) Biodegradation of gaseous toluene with mixed microbial consortium in a biofilter: steady state and transient operation. Bioprocess Biosyst Eng 40(12):1801–1812. https://doi.org/10.1007/s00449-017-1834-7
doi: 10.1007/s00449-017-1834-7 pubmed: 28871335
Ratiu IA, Bocos-Bintintan V, Monedeiro F, Milanowski M, Ligor T, Buszewski B (2020) An optimistic vision of future: diagnosis of bacterial infections by sensing their associated volatile organic compounds. Crit Rev Anal Chem 50(6):501–512. https://doi.org/10.1080/10408347.2019.1663147
doi: 10.1080/10408347.2019.1663147 pubmed: 31514505
Rowley J, Vander S, Korenromp E, Low N, Unemo M, Abu-Raddad LJ, Chico RM, Smolak A, Newman L, Gottlieb S, Thwin SS, Broutet N, Taylor MM (2019) Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates. Bull World Health Organ 97(8):548–562P. https://doi.org/10.2471/blt.18.228486
doi: 10.2471/blt.18.228486
Schneider RE, Brown MT, Shiflett AM, Dyall SD, Hayes RD, Xie Y, Loo JA, Johnson PJ (2011) The Trichomonas vaginalis hydrogenosome proteome is highly reduced relative to mitochondria, yet complex compared with mitosomes. Int J Parasitol 41(13–14):1421–1434. https://doi.org/10.1016/j.ijpara.2011.10.001
doi: 10.1016/j.ijpara.2011.10.001 pubmed: 22079833 pmcid: 4437511
Schwebke JR, Burgess D (2004) Trichomoniasis. Clin Microbiol Rev 17(4):794–803. https://doi.org/10.1128/cmr.17.4.794-803.2004
doi: 10.1128/cmr.17.4.794-803.2004 pubmed: 15489349 pmcid: 523559
Sethi S, Nanda R, Chakraborty T (2013) Clinical application of volatile organic compound analysis for detecting infectious diseases. Clin Microbiol Rev 26(3):462–475. https://doi.org/10.1128/cmr.00020-13
doi: 10.1128/cmr.00020-13 pubmed: 23824368 pmcid: 3719490
Sherrard J, Ison C, Moody J, Wainwright E, Wilson J, Sullivan A (2014) United Kingdom national guideline on the management of Trichomonas vaginalis 2014. Int J STD AIDS 25(8):541–549. https://doi.org/10.1177/0956462414525947
doi: 10.1177/0956462414525947 pubmed: 24616117
Smutná T, Dohnálková A, Sutak R, Narayanasamy RK, Tachezy J, Hrdý I (2022) A cytosolic ferredoxin-independent hydrogenase possibly mediates hydrogen uptake in Trichomonas vaginalis. Curr Biol 32(1):124-135.e5. https://doi.org/10.1016/j.cub.2021.10.050
doi: 10.1016/j.cub.2021.10.050 pubmed: 34762819
Sood S, Mohanty S, Kapil A, Tolosa J, Mittal S (2007) InPouch TV culture for detection of Trichomonas vaginalis. Indian J Med Res 125(4):567–571
pubmed: 17598943
Soper D (2004) Trichomoniasis: under control or undercontrolled? Am J Obstet Gynecol 190(1):281–290. https://doi.org/10.1016/j.ajog.2003.08.023
doi: 10.1016/j.ajog.2003.08.023 pubmed: 14749674
Sutak R, Hrdy I, Dolezal P, Cabala R, Sedinová M, Lewin J, Harant K, Müller M, Tachezy J (2012) Secondary alcohol dehydrogenase catalyzes the reduction of exogenous acetone to 2-propanol in Trichomonas vaginalis. FEBS J 279(15):2768–2780. https://doi.org/10.1111/j.1742-4658.2012.08661.x
doi: 10.1111/j.1742-4658.2012.08661.x pubmed: 22686835
Tachezy J, Makki A, Hrdý I (2022) The hydrogenosome of Trichomonas vaginalis J Eukaryot Microbiol e12922 https://doi.org/10.1111/jeu.12922
Urbański LJ, Angeli A, Mykuliak VV, Azizi L, Kuuslahti M, Hytönen VP, Supuran CT, Parkkila S (2022) Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis. J Mol Med (berl) 100(1):115–124. https://doi.org/10.1007/s00109-021-02148-1
doi: 10.1007/s00109-021-02148-1 pubmed: 34652457
Vogt MS, Schühle K, Kölzer S, Peschke P, Chowdhury NP, Kleinsorge D, Buckel W, Essen LO, Heider J (2019) Structural and functional characterization of an electron transfer flavoprotein involved in toluene degradation in strictly anaerobic bacteria. J Bacteriol 201 21 e00326–19. https://doi.org/10.1128/JB.00326-19

Auteurs

Ricardo Rubio-Sánchez (R)

Servicio de Análisis Clínicos, Hospital Universitario Virgen de Valme, 41014, Seville, Spain.

Rocío Ríos-Reina (R)

Área de Nutrición y Bromatología, Departamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, 41012, Seville, Spain. rrios5@us.es.

Cristina Ubeda (C)

Área de Nutrición y Bromatología, Departamento de Nutrición y Bromatología, Toxicología y Medicina Legal, Facultad de Farmacia, Universidad de Sevilla, 41012, Seville, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH